NPI: 1871971556 · TAMPA, FL 33606 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/13/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/13/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,297 | $151K |
| 2019 | 14,285 | $2.21M |
| 2020 | 17,559 | $2.00M |
| 2021 | 9,200 | $658K |
| 2022 | 5,816 | $677K |
| 2023 | 421 | $82K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,972 | 1,068 | $2.01M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,171 | 742 | $1.79M |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,685 | 431 | $844K |
| J1756 | Injection, iron sucrose, 1 mg | 4,104 | 597 | $423K |
| A4657 | Syringe, with or without needle, each | 2,001 | 785 | $391K |
| 85041 | 612 | 401 | $75K | |
| 85048 | 507 | 341 | $69K | |
| 83970 | 470 | 329 | $58K | |
| 83540 | 304 | 203 | $37K | |
| 83550 | 304 | 203 | $37K | |
| 82728 | 265 | 177 | $33K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 97 | 44 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 50 | 39 | $6K |
| 82108 | 36 | 27 | $4K |